×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Practical Desicion Making Across TheLlifecycle: Quantitative benefit risk analysis
Session Chair(s)
John Parkinson, PhD
Director
CPRD, United Kingdom
Practical Decision Making Across The Lifecycle: Quantitative benefit risk analysis
Speaker(s)
Modeling and Simulation in Early Drug Development
Guenter Heimann
Novartis Pharma AG, Switzerland
Unit Head Pharmacometrics
Ed Waddingham, MSc
Imperial College London, United Kingdom
Imperial Clinial Trials Unit
Statistical Challenges in Post Licensing Benefit Risk - A Regulatory view
Andrew Thomson, PhD, MA, MS
European Medicines Agency, Netherlands
Statistician, Methodology Taskforce
Robert Hemmings, MSc
Critical Path Institute, United States
Partner
Stuart J Pocock, PhD, MSc
London School of Hygiene and Tropical Medicine, United Kingdom
Epidemiology and Population Health
Mouna Akacha, PhD
Novartis Pharma AG, Switzerland
Group Head of Statistical Methodology
Have an account?